Sinew Pharma Inc. (TPEX:6634)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.80
+1.10 (2.13%)
Sep 8, 2026, 12:57 PM CST

Sinew Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,6872,7923,3924,7987,3265,659
Market Cap Growth
9.65%-17.69%-29.30%-34.51%29.47%19.05%
Enterprise Value
2,5311,7072,1853,4685,8954,354
Last Close Price
51.7039.1547.5567.70105.0082.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
78446.3859405.82--22335.55908.45
PB Ratio
3.552.562.833.635.023.61
P/TBV Ratio
3.602.602.893.735.223.77

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-36314.06--17973.83699.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.000.010.010.00
Net Debt / Equity Ratio
-0.95-0.95-0.97-0.96-0.95-0.94
Net Debt / EBITDA Ratio
7.708.167.987.7410.7920.06
Net Debt / FCF Ratio
10.0010.8110.8810.1113.9824.90
Asset Turnover
00--00.01
Quick Ratio
46.3542.2343.4336.7860.5499.08
Current Ratio
46.4342.2843.4636.8160.5699.36
Return on Equity (ROE)
-10.85%-10.81%-11.93%-12.29%-9.26%-9.14%
Return on Assets (ROA)
-7.40%-7.44%-8.15%-8.17%-6.04%-5.79%
Return on Capital Employed (ROCE)
-12.70%-12.70%-14.10%-14.00%-10.10%-6.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.21%-4.43%-4.43%-3.56%-1.91%-1.62%
FCF Yield
-2.67%-3.44%-3.13%-2.61%-1.35%-1.05%
Buyback Yield / Dilution
-0.08%0.37%-1.21%-1.68%-16.47%-19.41%